Compare
CHE vs CVS vs CI vs LH
Up to five stocks or ETFs side by side. Performance is rebased to 100 at the start of the window.
Relative performance
| CHE | CVS | CI | LH | |
|---|---|---|---|---|
| Price | $528.05 | $83.85 | $293.59 | $366.57 |
| 1-day | -1.07% | +3.10% | -2.62% | +0.90% |
| YTD | +23.42% | +5.66% | +6.67% | +46.11% |
| 1 year | +20.28% | +6.75% | +13.10% | +46.22% |
| 3 years | -8.32% | +22.00% | -5.11% | +79.74% |
| Market cap | $6.9B | $107.3B | $77.4B | $29.8B |
| P/E | 25.3 | 9.7 | 12.9 | 30.1 |
| P/S | 2.58 | 0.26 | 0.27 | 2.04 |
| P/B | 7.98 | 1.33 | 1.78 | 3.36 |
| Revenue growth | +15.60% | +6.70% | +6.80% | +6.00% |
| EPS growth | +10.40% | +2107.70% | +0.30% | +19.60% |
| Gross margin % | 33.5 | 44.2 | 20.7 | 29.0 |
| Net margin % | 10.6 | 2.6 | 2.1 | 6.9 |
| ROE % | 32.8 | 13.7 | 13.8 | 11.3 |
| Debt / equity | 0.28 | 0.75 | 0.72 | 0.66 |
| FCF yield % | 4.3 | 14.5 | 12.2 | 4.3 |
| Dividend yield % | 0.47 | 3.17 | 2.11 | 0.79 |
| Beta | 0.10 | -0.06 | 0.08 | 0.38 |
| RSI (14) | 53.0 | 39.9 | 49.6 | 69.9 |
| Technical rating |